Penumbra, Inc. (PEN)

NASDAQ

$309.01

-$3.00 (0.96%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$308.10$315.74

Open $312.50

52 Week Range

$221.26$315.72

Previous Close $312.02

Market Cap12.10B

Volume316.85K

Avg Volume495.80K

P/E (TTM)74.33

EPS (TTM)$4.20

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for Penumbra, Inc.

NOV192025

Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference

Source: PRNewsWire•26 days ago

ALAMEDA, Calif. , Nov. 19, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025....

NOV52025

Penumbra, Inc. Reports Third Quarter 2025 Financial Results

Source: PRNewsWire•40 days ago

ALAMEDA, Calif. , Nov. 5, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2025....

NOV32025

Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism

Source: PRNewsWire•42 days ago

The STORM-PE RCT data presented at the VIVA 2025 Conference showed PE patients treated with CAVT in combination with anticoagulation demonstrated significantly greater improvements in thrombus burden reduction, heart rate, oxygen requirement, and fun...

OCT272025

Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism

Source: PRNewsWire•49 days ago

ALAMEDA, Calif. , Oct. 27, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the results of the landmark STORM-PE randomized controlled trial (RCT), which found that the use of mechanical thrombectomy, specifically computer assisted vacuum th...

OCT82025

Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025

Source: PRNewsWire•68 days ago

ALAMEDA, Calif. , Oct. 8, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host an investor event on Sunday, October 26, 2025 from 4:00-5:00 PM Pacific Time / 7:00-8:00 PM Eastern Time at the 2025 Transcatheter Cardiovascu...